Skip to main content
. 2022 Jul 14;140(2):112–120. doi: 10.1182/blood.2021014960

Figure 3.

Figure 3.

PFS by CLL IPI risk group. (A) PFS by CLL IPI risk group for FCR-treated patients; (B) PFS by CLL IPI risk group for IR-treated patients; (C) PFS by treatment arm within each CLL IPI risk group.